Protalix Biotherapeutics Inc (PLX)
Cost of Revenue
$24.83M
TTM · Period ending: · USD
PLX Cost of Revenue
Latest reported$24.83Mperiod ending
Latest reported$24.83Mperiod ending
PLX TTM Cost of Revenue ($0.00 → $24.83M)
TTM cost of revenue
High-resolution chart · PNG
PLX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 23,493 | |
| 176,227 | |
| 1,072,850 | |
| 2,683,850 | |
| 3,610,357 | |
| 4,527,623 | |
| 4,471,000 | |
| 2,860,000 | |
| 1,910,000 | |
| 840,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |